Global Structural Heart Devices Market- Market Overview:

The global Structural Heart Devices market is expected to grow from USD 13.4 billion in 2022 to USD 31.7 billion by 2030, at a CAGR of 11.3% during the Projection period 2023-2030. The increase in incidences of zoonotic diseases mainly drives the growth of the Structural Heart Devices market.

The heart is a very vital body organ. To keep the other organs operating, it pumps blood. It is crucial to maintain its health because it continuously pumps blood without stopping. However, as a result of a lack of exercise and bad eating habits, heart disease has become more prevalent. Similar to this, other factors, like rising alcohol intake and drug usage, are also contributing to an increase in heart patients. The walls, valves, muscles, and chambers of the heart are all harmed in structural heart disorders. Chest aches and weariness are brought on by such injury, which inhibits blood flow. The prevalence of congenital cardiac disease in infants has grown as a result of smoking, drinking, and high-dose drug use during pregnancy. Congenital heart disease cases have increased as a result of similar practises in adults. Globally, there has been an increase in other structural heart problems as well. The injured heart's chambers, valves, muscles, or other structural components are repaired or replaced using structural heart devices. They enhance blood flow and are implanted in the heart. Surgery performed with these technologies is less intrusive, which enhances patient results and prolongs their life. Their standard of living has increased. The global market for structural heart devices will continue to grow as a result of medical progress.

Sample Request: - Global Structural Heart Devices Market

Market Dynamics:

Drivers:

• Increased prevalence of structural heart disorders

Diseases of the heart's muscles, valves, walls, or chambers are referred to as structural heart diseases. Common structural heart problems include cardiomyopathy, heart valve disorders, and congenital heart conditions. Infants can develop structural heart disorders, and adults can also get them. The prevalence of structural heart disorders has increased. In the USA, for instance, roughly the same number of adults are diagnosed with congenital heart illnesses each year as there are congenital heart disease sufferers among children worldwide. Similar to that, cardiomyopathy affects thousands of people. Congenital heart disease can be brought on by the side effects of some drugs, strong alcohol use, and drug use while smoking, but it can also develop with age if there is substance addiction. The prevalence of stress-relieving behaviours such as drinking, smoking, and using medications has increased people's risk of structural heart disease. Similar to this, the prevalence of heart attacks has raised people's susceptibility to structural heart problems. Patients with structural heart disease are becoming more prevalent, which is also being fueled by disorders including hypertension, high blood pressure, autoimmune diseases, and others. The global market for structural cardiac devices will therefore be driven by the rising prevalence of structural heart disorders.

Restraints:                                             

• The cost of structural heart devices is high

Developing sophisticated diagnostic and therapeutic methods costs billions of dollars. High-cost inputs used in the creation of any therapy or product include medical equipment, drugs, and personnel. However, the success or completeness of any testing for a novel drug or device cannot always be guaranteed. These failed attempts at medical advancement cost a lot of money. The prosperous ones have also made large financial investments. Research and development for structural cardiac devices take time and money. To continue developing new treatments or gadgets, the money that was spent on research and development of successful projects must be recovered when the product is sold. Because of this, the market actors demand high prices for these sophisticated, expensive, and successful structural heart implants. The price of structural cardiac devices will be a restriction on market growth.

Opportunities:

• Technological advancements and increasing research and development expenditure

Government organisations all over the world have increased research and development spending in order to better the countries' infrastructure for diagnosis and treatment as a result of the rising incidence of structural heart disorders. The medical industry has been able to improve medical devices, pharmaceuticals, therapies, and treatments in order to make them more efficient, affordable, and available to the general public. Pharmaceutical and biotechnology businesses are now concentrating on the diagnosis and treatment of ailments that were previously ignored thanks to the advancements in global healthcare over the years. The infrastructure for diagnosing and treating structural heart disorders has therefore been strengthened as a result of technical developments and rising research and development spending. The structural heart devices market will continue to improve and provide industry participants with profitable chances.

Challenges:

• Stringent regulatory guidelines

While structural heart devices can prolong and improve the patient's quality of life, they also carry a risk of injury if necessary precautions are not taken during their approval or monitoring for commercial usage. These gadgets have the potential to have an immediate negative effect on the patients and result in serious, permanent harm. Deaths that are unavoidable can result from lax rules and regulations. To protect the interests of consumers, strict regulations control both the approval of structural cardiac devices and the subsequent monitoring of their use. These laws and regulations are carried out by national institutions. They are in charge of the populace and hold large pharmaceutical firms accountable when mistakes are made. Such rigidity may deter companies from pursuing projects that advance medicine by causing delays in approvals that are harmful to their operations. The market's expansion will be hampered by the government's strict controls.

Segmentation Analysis:

The global Structural Heart Devices market has been segmented based on indication, product type, procedure, and region.

By Indication

The indication segment is divided into atrial septal defects, aortic valvular disease, pulmonary valvular disease, patent foramen ovale, ventricular septal defects, mitral valvular disease, patent ductus arteriosus, and others. The aortic valvular disease segment dominated the market with a market share of around 25% in 2022. The aorta and aortic valvular disease are related, as the name would imply. The artery called the aorta is in charge of transferring oxygenated blood from the heart to the rest of the body. The aorta does not fully open when there is aortic valvular disease. Low levels of oxygen are delivered to the remainder of the body as a result of the restricted blood flow brought on by the incomplete relaxation of the aorta wall/muscles. To move oxygen, the heart must work harder. Chest pain and exhaustion result from this. In the world, aortic valvular disease is fairly prevalent. Through minimally invasive surgical techniques, a structural cardiac device is implanted to treat it. As a result, the indication section will be dominated by aortic valvular disease.

By Indication

The product type segment is divided into heart valve devices, annuloplasty rings, occluders and delivery systems, transcatheter mitral valve repair, and others. The heart valve devices segment dominated the market with a market share of around 45% in 2022. The number of monocytes, neutrophils, and lymphocytes in the blood can be determined via a 3-part WBC differential. Most medical or veterinary hospitals, clinics, and diagnostic labs have these analyzers. They are well-liked in the veterinary industry since they provide adequate diagnostic information to identify the illness or condition afflicting the animal or pet. It is effective and efficient at finding bacterial and viral illnesses. The market use of 3-part WBC differential analyzers is increasing due to the significant frequency of zoonotic illnesses, primarily bacterial or viral.

By End-user

The procedure segment is divided into repair and replacements. The replacement segment dominated the market with a market share of around 65% in 2022. The quality of life is reduced by structural heart problems since they cause persistent chest pain and exhaustion. The repairs made by giving drugs or performing surgical procedures do not completely ensure the treatment's lifespan. Additionally, repairs lose some of their effectiveness over time, subjecting the patient to additional stress. The need for replacement has grown as a result of the development of superior, flexible, sophisticated, resilient, and highly effective structural cardiac devices. Replacement enhances blood flow and increases the likelihood that the patient will live a longer life. A successful long-term alternative to repair methods is replacement.

Global Structural Heart Devices Market - Sales Analysis.

The sale of Structural Heart Devices market expanded at a CAGR of % from 2016 to 2022.

The market for structural heart devices is driven by factors such as the rise in incidence of structural heart diseases (such as aortic stenosis and mitral regurgitation), technological advancements, the creation of novel repair devices like annuloplasty rings and occluders, and an increase in demand for minimally invasive procedures. High surgical costs and onerous regulatory regulations, however, limit this progress. The need for rapid and durable operations among the senior population and the increased focus of key manufacturers on structural heart device R&D efforts, on the other hand, are predicted to create lucrative prospects for the market's players.

The main drivers of the structural heart devices market are the rising prevalence of various structural heart diseases, the surge in expanded indication approval for various transcatheter structural heart products, and the rise in the geriatric population affected by various degenerative valvular heart diseases. The growing preference for minimally invasive structural heart therapeutic products among patients who place a premium on value and the increase in research and development spending for the creation of cutting-edge, innovative products all contribute to the market growth for structural heart devices.

Thus, owing to the aforementioned factors, the global Structural Heart Devices market is expected to grow at a CAGR of 11.3% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the structural heart devices market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the structural heart devices market and held a 40% share of the market revenue in 2022.

• The North American region witnessed a major share. The existence of a substantial population who suffer from structural heart disorders is one of the industry's primary motivations. The well-established healthcare infrastructure, which also has a sophisticated and extensive testing network, enables early diagnosis of structural cardiac disorders. Additionally, quick access to therapies is offered. The rising prevalence of the illness will also help the middle-aged population's market expand. Well-established paediatric care is a significant secondary factor that enables early detection and treatment of infant congenital heart disease. Major pharmaceutical and biotechnology companies are primarily focused on the research and development of structural cardiac devices. Numerous scientific breakthroughs made possible by a robust scientific community and research infrastructure have led to the creation of sophisticated, minimally invasive, and highly effective structural cardiac devices. The market's rise is aided by the substantial insurance protection system and governmental healthcare initiatives.
• Asia Pacific is anticipated to experience significant growth during the Projection period. The market for structural heart devices is positively impacted by rising healthcare facility demand, a good reimbursement environment, and rising structural heart disease awareness in the region. Furthermore, the presence of large population pool in the region suffering from heart diseases also adds impetus to the market’s growth.

Global Structural Heart Devices Market - Country Analysis:

• Germany

Germany's structural heart devices market size was valued at USD 0.92 billion in 2022 and is expected to reach USD 2.18 billion by 2030, at a CAGR of 11.4% from 2023 to 2030. The increase in surgeries, the prevalence of cardiovascular illnesses, and the demand for more sophisticated treatment methods are all contributing factors to the market expansion in Germany.

• China

China’s structural heart devices market size was valued at USD 0.98 billion in 2022 and is expected to reach USD 2.37 billion by 2030, at a CAGR of 11.7% from 2023 to 2030. The market's expansion in China can be ascribed to rising cardiac disease awareness, improved neonatal screening programmes, and expanded access to healthcare. Significant market participant investment and improvements in the healthcare infrastructure are key growth drivers in China.

• India

India's structural heart devices market size was valued at USD 0.76 billion in 2022 and is expected to reach USD 1.8 billion by 2030, at a CAGR of 11.6% from 2023 to 2030. The market's expansion in India is fueled by the availability of top-notch medical facilities, increased demand for cutting-edge technology, better adoption rates, rising disposable income, and expanding medical tourism.  The structural heart devices and procedures are projected to command the biggest market share in terms of volume because to increased life expectancy and inexpensive prices.

Key Industry Players Analysis:

To increase their market position in the global Structural Heart Devices market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.   

• Boston Scientific Corporation
• Medtronic
• Edwards Lifesciences Corporation
• Abbott Laboratories
• JUDE MEDICAL
• Biomerics,
• Comed BV
• LivaNova PLC
• JenaValve Technology Inc.,
• CardioKinetix

Latest Development:

• In May 2022, An innovative, minimally invasive vascular heart valve repair device was unveiled by Abbott and Laboratories. New information was also provided by the company about Amplatzer Amulet and MitraClip, two essential items in its market-leading structural cardiac portfolio.
• In May 2022, Under the term Balloons & Balloon Catheters Centre of Excellence, Biomerics announced its growth in Ireland, with Galway as a prospective location.
• In December 2022, For patients in India who have severe aortic stenosis and are at high or extremely high risk for surgery, global healthcare company Abbott has made Navitor, the most recent generation of transcatheter aortic valve implantation (TAVI) technology, available. The producer of the Navitor valve claims to be improving transcatheter aortic valve replacement (TAVI or TAVR) therapies by developing a unique design to prevent blood from leaking around the valve. The company's vast structural heart transcatheter portfolio just gained the Navitor TAVI system, which is the newest addition. It gives medical professionals and patients less invasive options for managing heart conditions.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	11.3%
Market Size	13.4 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Indication, By Product Type, By Procedure, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, Abbott Laboratories, ST. JUDE MEDICAL, Biomerics, Comed BV, LivaNova PLC, JenaValve Technology Inc., and CardioKinetix.
By Indication	Atrial Septal Defects Aortic Valvular Disease Pulmonary Valvular Disease Patent Foramen Ovale Ventricular Septal Defects Mitral Valvular Disease Patent Ductus Arteriosus Others
By Product Type	Heart Valve Devices Annuloplasty Rings Occluders and Delivery Systems Transcatheter Mitral Valve Repair Others
By Procedure	Repair Replacements
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Structural Heart Devices Market By Indication:

• Atrial Septal Defects
• Aortic Valvular Disease
• Pulmonary Valvular Disease
• Patent Foramen Ovale
• Ventricular Septal Defects
• Mitral Valvular Disease
• Patent Ductus Arteriosus
• Others

Global Structural Heart Devices Market By Product Type :

• Heart Valve Devices
• Annuloplasty Rings
• Occluders and Delivery Systems
• Transcatheter Mitral Valve Repair
• Others

Global Structural Heart Devices Market By Procedure:

• Repair
• Replacements

Global Structural Heart Devices Market By Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- The foundation of the current form of government, which supports the activities of the structural heart devices market, is democracy. The democratic political system, which promotes initiative and free trade, offers financial freedom that the structural heart devices market can take advantage of. Pressure groups can alter the business environment by forming strong media alliances. These organisations are under pressure from these groups, which arrange protests and coordinate marketing campaigns. The structural heart devices market needs to keep a watch on these pressure organisations because they have the ability to influence government legislation, which could ultimately have an effect on the broader business climate. The structural heart devices market should collaborate closely with these groups in order to earn their trust.

Economic Factors- The economic growth rates of the various countries should be taken into account when selecting whether or not to expand abroad for the structural heart devices market. In countries with strong rates of economic growth, there are more possibilities for pursuing long-term growth objectives. When the economy is expanding slowly, consumer purchasing becomes more circumspect, which directly affects the revenue growth of the structural heart devices market. Rising inflation may negatively affect the ability of the structural heart devices market to increase its income since it lowers the purchasing power of money and discourages consumers from making purchases of products and services.

Social factors- Every country has unique cultural norms, values, and traditions that shape how people behave in everyday life, including as customers. Lack of adaptability to change product/service offerings in line with local cultural practises could have a negative impact on the business. To understand local consumers, the structural heart devices market needs to conduct extensive research. The fact that the management of the structural heart devices market is an international company with a culturally diverse home market may make it difficult for them to understand the subtle cultural distinctions. To do this, the structural heart devices market can forge business ties with regional market players that may be able to share in-depth understanding of the cultural norms and values that influence how consumers perceive and engage with the brand.

Technological Factors- Since these countries make it easier for enterprises to achieve objectives like cost reduction, innovation, and value creation, the structural heart devices market should favour those countries with superior technology infrastructure. Because it can be simple for competitors to copy, a technologically advanced infrastructure also indicates that it will be more challenging for the structural heart devices market to leverage technology to create a sustained competitive advantage. The market and industry as a whole may be affected by the speed and advancement of technical innovation. By studying the upcoming technological innovation trends, the structural heart devices market will be able to comprehend the rate of new product development, the length of the product life cycle, and the distinctive features that consumers prefer.

Environmental Factors- Due to stringent environmental legislation in many different nations, businesses are under pressure to reduce environmental impact. In order to avoid harsh, reputation-damaging criticism from relevant stakeholders, the structural heart devices market should adopt ethical production practises, encourage ethical consumption among its target market, work to improve its brand's sustainability reputation, and ensure full compliance with local and international environmental laws.

Legal Factors Strict adherence to intellectual property laws benefits businesses like the structural heart devices market since it protects their patents from infringement and gives them a long-lasting competitive advantage. In many countries, there are numerous federal and state laws in place to protect consumers from potential economic exploitation. In the era of information technology, laws have become considerably stricter to safeguard consumer privacy. In order to avoid lawsuits, the structural heart devices market must rigorously adhere to the data privacy rules when conducting online transactions. Before entering new markets, structural heart devices market management must examine regional laws governing returns, discounts, credit terms, quality, deceptive advertising, and maximum pricing (particularly in the case of basic essential goods).

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Indication
     • 3.2. Market Attractiveness Analysis By Product Type
     • 3.3. Market Attractiveness Analysis By Procedure
     • 3.4. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Increased prevalence of structural heart disorders
   • 3. Restraints
     • 3.1. The cost of structural heart devices is high
   • 4. Opportunities
     • 4.1. Technological advancements and increasing research and development expenditure
   • 5. Challenges
     • 5.1. Stringent regulatory guidelines

6. Global Structural Heart Devices Market Analysis and Projection, By Indication
   • 1. Segment Overview
   • 2. Atrial Septal Defects
   • 3. Aortic Valvular Disease
   • 4. Pulmonary Valvular Disease
   • 5. Patent Foramen Ovale
   • 6. Ventricular Septal Defects
   • 7. Mitral Valvular Disease
   • 8. Patent Ductus Arteriosus
   • 9. Others
7. Global Structural Heart Devices Market Analysis and Projection, By Product Type
   • 1. Segment Overview
   • 2. Heart Valve Devices
   • 3. Annuloplasty Rings
   • 4. Occluders and Delivery Systems
   • 5. Transcatheter Mitral Valve Repair
   • 6. Others
8. Global Structural Heart Devices Market Analysis and Projection, By Procedure
   • 1. Segment Overview
   • 2. Repair
   • 3. Replacements
9. Global Structural Heart Devices Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

10. Global Structural Heart Devices Market-Competitive Landscape
    • Overview
    • Market Share of Key Players in the Structural Heart Devices Market
      • 2.1. Global Company Market Share
      • 2.2. North America Company Market Share
      • 2.3. Europe Company Market Share
      • 2.4. APAC Company Market Share
    • Competitive Situations and Trends
      • 3.1. Product Launches and Developments
      • 3.2. Partnerships, Collaborations, and Agreements
      • 3.3. Mergers & Acquisitions
      • 3.4. Expansions

11. Company Profiles
    • Boston Scientific Corporation
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Product Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Medtronic
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Product Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Edwards Lifesciences Corporation
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Product Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Abbott Laboratories
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Product Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • JUDE MEDICAL
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Product Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Biomerics,
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Product Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • Comed BV
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Product Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • LivaNova PLC
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Product Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • JenaValve Technology Inc.,
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Product Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • CardioKinetix
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
2. Global Atrial Septal Defects, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
3. Global Aortic Valvular Disease, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
4. Global Pulmonary Valvular Disease, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
5. Global Patent Foramen Ovale, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
6. Global Ventricular Septal Defects, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
7. Global Mitral Valvular Disease, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
8. Global Patent Ductus Arteriosus, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
9. Global Others, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
10. Global Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
11. Global Heart Valve Devices, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
12. Global Annuloplasty Rings, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
13. Global Occluders and Delivery Systems, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
14. Global Transcatheter Mitral Valve Repair, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
15. Global Others, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
16. Global Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
17. Global Repair, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
18. Global Replacements, Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
19. Global Structural Heart Devices Market, By Region, 2023–2030 (USD Billion)
20. North America Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
21. North America Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
22. North America Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
23. USA Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
24. USA Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
25. USA Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)  
26. Canada Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
27. Canada Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
28. Canada Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
29. Mexico Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
30. Mexico Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
31. Mexico Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
32. Europe Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
33. Europe Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
34. Europe Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
35. Germany Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
36. Germany Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
37. Germany Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
38. France Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
39. France Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
40. France Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
41. UK Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
42. UK Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
43. UK Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
44. Italy Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
45. Italy Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
46. Italy Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
47. Spain Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
48. Spain Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
49. Spain Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
50. Asia Pacific Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
51. Asia Pacific Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
52. Asia Pacific Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
53. Japan Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
54. Japan Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
55. Japan Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
56. China Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
57. China Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
58. China Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
59. India Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
60. India Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
61. India Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
62. South America Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
63. South America Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
64. South America Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
65. Brazil Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
66. Brazil Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
67. Brazil Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
68. Middle East and Africa Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
69. Middle East and Africa Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
70. Middle East and Africa Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
71. UAE Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
72. UAE Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
73. UAE Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)
74. South Africa Structural Heart Devices Market, By Indication, 2023–2030 (USD Billion)
75. South Africa Structural Heart Devices Market, By Product Type, 2023–2030 (USD Billion)
76. South Africa Structural Heart Devices Market, By Procedure, 2023–2030 (USD Billion)

List of Figures 

1. Global Structural Heart Devices Market Segmentation
2. Structural Heart Devices Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Structural Heart Devices Market Attractiveness Analysis By Indication
9. Global Structural Heart Devices Market Attractiveness Analysis By Product Type
10. Global Structural Heart Devices Market Attractiveness Analysis By Procedure
11. Global Structural Heart Devices Market Attractiveness Analysis By Region
12. Global Structural Heart Devices Market: Dynamics
13. Global Structural Heart Devices Market Share By Indication (2023 & 2030)
14. Global Structural Heart Devices Market Share By Product Type (2023 & 2030)
15. Global Structural Heart Devices Market Share By Procedure (2023 & 2030)
16. Global Structural Heart Devices Market Share by Regions (2023 & 2030)
17. Global Structural Heart Devices Market Share by Company (2021)